Dr. Daniel Berger, MD

Dr. Berger practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Berger's NPI, 1073950390, was assigned on May 28, 2013. Dr. Berger graduated from R Franklin University of Med & Sci/Chicago Medical School in 2013. Dr. Berger holds Illinois license 036148765.

Dr. Berger's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Berger also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Berger's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. Dr. Berger is also affiliated with Holy Cross Hospital. The medical group on file is Sinai Medical Group. Dmand AI also links Dr. Berger to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berger practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Berger's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Berger is licensed in Illinois.

CMS data shows 228 Medicare services from Dr. Berger across 7 procedure codes in 2024, for 156 Medicare patients. Medicare paid $25,534 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Berger in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berger's median patient age at 64, with 54% women.

In 2024, Dr. Berger wrote 190 Medicare Part D claims for 110 patients. 82% of them were for generic drugs. CMS names the drug for 111 of them, across 4 drugs with 11 or more claims each, at $1,404 in total drug cost. In 2023, CMS named 89 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Berger for performance year 2024, reported as part of a group. Dr. Berger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berger as offering telehealth. CMS counts 44 procedures of colonoscopy by Dr. Berger, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Berger, published from 2003 to 2019. 2018 was the busiest year, with 2. The most frequent topics are Adenoma, Colonoscopy and Colorectal Neoplasms. Dr. Berger has published most often in Gastrointest Endosc. Dr. Berger's most frequent co-authors are Karen Hsia Ma, MD, PharmD, Mohamed Moatez Bayoumi, MD and Diana Marina Brainard, MD.

Dmand AI links Dr. Berger to 1 clinical trial.

CMS Open Payments shows 234 general payments to Dr. Berger from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Medtronic, Inc. paid the most, $55,491.

Dr. Berger graduated from R Franklin University of Med & Sci/Chicago Medical School in 2013.